MARATTO

article · Parasitology International

A high prevalence of dogs seropositive to Leishmania in Zambia

20253 citationsOpen accessUniversity Teaching Hospital

Abstract

Domestic dogs are the main reservoir of Leishmania infantum, a causative agent of visceral leishmaniasis in humans. Although the disease is widespread in the world, the burden of visceral or any other disease form of leishmaniasis is poorly documented in Zambia, largely due to lack of surveillance. Recently, three cases of autochthonous canine leishmaniasis (CanL) were reported in Zambia following decades of presumed disease absence. This finding intimated probable disease emergence, raising the need for the identification of infection foci. Thus, in this study, we conducted the first mass serological survey for Leishmania infections in domestic dogs from two densely populated urban areas of Zambia in July 2022. In some of the study sites, seropositivity was up to ∼17 %, suggesting probable presence of Leishmania transmission hot spots. Moreover, on follow-up surveys of seropositive dogs, presence of antileishmanial antibodies was a risk factor for dog survival (relative risk = 7.9; odds ratio = 42.5). Our findings implies that Leishmania infection can be a health issue in domestic dogs in Zambia. Considering the risk of zoonotic transmission, the need for improved disease diagnosis and surveillance in both humans, dogs and sand fly vectors is highlighted in Zambia.

Research topics

  • Research on Leishmaniasis Studies
  • Trypanosoma species research and implications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.parint.2025.103081

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.